These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1902389)

  • 21. Liver-lung interactions during E. coli endotoxemia. TNF-alpha:leukotriene axis.
    Matuschak GM; Mattingly ME; Tredway TL; Lechner AJ
    Am J Respir Crit Care Med; 1994 Jan; 149(1):41-9. PubMed ID: 8111596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha.
    Shinozuka H; Ohmura T; Katyal SL; Zedda AI; Ledda-Columbano GM; Columbano A
    Hepatology; 1996 Jun; 23(6):1572-7. PubMed ID: 8675179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats.
    Toxic Rep Ser; 2000 Feb; 46():1-C7. PubMed ID: 11986676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-6, but not tumour necrosis factor-alpha, increases lipogenesis in rat hepatocyte primary cultures.
    Brass EP; Vetter WH
    Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):193-7. PubMed ID: 8037670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
    Thatch KA; Schwartz MZ; Yoo EY; Mendelson KG; Duke DS
    J Pediatr Surg; 2008 Dec; 43(12):2169-73. PubMed ID: 19040928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury.
    Katz MS; Thatch KA; Schwartz MZ
    J Surg Res; 2010 Oct; 163(2):294-8. PubMed ID: 20691983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury.
    Piao N; Ikejima K; Kon K; Aoyama T; Osada T; Takei Y; Sato N; Watanabe S
    Life Sci; 2009 Oct; 85(17-18):617-24. PubMed ID: 19647752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of microthrombus formation in the development of ischemia/reperfusion-induced liver injury in rats.
    Okajima K; Harada N; Kushimoto S; Uchiba M
    Thromb Haemost; 2002 Sep; 88(3):473-80. PubMed ID: 12353078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.
    Lang CH; Dobrescu C; Bagby GJ
    Endocrinology; 1992 Jan; 130(1):43-52. PubMed ID: 1727716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.
    Teoh N; Leclercq I; Pena AD; Farrell G
    Hepatology; 2003 Jan; 37(1):118-28. PubMed ID: 12500196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat.
    Peralta C; Prats N; Xaus C; Gelpí E; Roselló-Catafau J
    Hepatology; 1999 Dec; 30(6):1481-9. PubMed ID: 10573528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor primes hepatocytes for DNA replication in the rat.
    Webber EM; Bruix J; Pierce RH; Fausto N
    Hepatology; 1998 Nov; 28(5):1226-34. PubMed ID: 9794905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
    Tang ZY; Loss G; Carmody I; Cohen AJ
    Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
    Thissen JP; Verniers J
    Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury.
    Eastin CE; McClain CJ; Lee EY; Bagby GJ; Chawla RK
    Alcohol Clin Exp Res; 1997 Sep; 21(6):1037-41. PubMed ID: 9309314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
    Tukov FF; Luyendyk JP; Ganey PE; Roth RA
    Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of urea synthesis during the acute phase response in rats.
    Thomsen KL
    Dan Med J; 2013 Apr; 60(4):B4617. PubMed ID: 23651724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early hepatic changes induced in rats by two hepatocarcinogenic organohalogen pesticides: bromopropylate and DDT.
    Kostka G; Kopeć-Szlezak J; Palut D
    Carcinogenesis; 1996 Mar; 17(3):407-12. PubMed ID: 8631124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.